
Keywords: AE; adverse event; API; active pharmaceutical ingredient; BDP; beclomethasone dipropionate; CF; cystic fibrosis; CFU; colony forming unit; CH; cholesterol; COPD; chronic obstructive pulmonary disease; DLPC; dilauroyl PC; DPI; dry powder inhaler; DPPC; dip